chartexchange

Roivant Sciences Ltd (ROIV) (Q2 2026) Earnings Call Highlights: LISRIA Launch Delivers $31 ...

GuruFocus | Nov 10, 2026 4:02 AM EST

Roivant Sciences Ltd (ROIV) posted a strong debut for LISRIA and breakthrough RA and pulmonary hypertension data, while navigating payer dynamics and regulatory uncertainty. Related Stocks: ROIV ,

Read original article